1
|
Zhang Z, Tai Y, Liu Z, Pu Y, An L, Li X, Li L, Wang Y, Yang Z, Duan C, Hou K, Zhang Q, Ren F, Ma Q, Su Y. Effects of d-ribose on human erythrocytes: Non-enzymatic glycation of hemoglobin, eryptosis, oxidative stress and energy metabolism. Blood Cells Mol Dis 2023; 99:102725. [PMID: 36682143 DOI: 10.1016/j.bcmd.2023.102725] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2022] [Revised: 01/10/2023] [Accepted: 01/10/2023] [Indexed: 01/15/2023]
Abstract
d-Ribose is not only an important component of some biomacromolecules, but also an active pentose with strong reducibility and non-enzymatic glycation ability. Previous studies reported the diverse role of d-ribose in different cells. In this study, the effects of d-ribose on non-enzymatic glycation of hemoglobin (Hb), as well as eryptosis, oxidative stress and energy metabolism of erythrocytes were observed by molecular fluorescence spectrophotometry, multi-wavelength spectrophotometry, high-pressure liquid chromatography (HPLC), mass spectrometry (MS) and flow cytometer. The results showed that d-ribose had the strongest non-enzymatic glycation ability to Hb in vitro when compared with other monosaccharides, and could enter the erythrocytes in a concentration-dependent manner, which was not inhibited by the specific glucose transporter 1 (GLUT1) inhibitor WZB117. In addition, d-ribose incubation increased the HbA1c, hemolysis, eryptosis, and ROS level of erythrocytes significantly more than that of d-glucose, however, no changes were observed in the levels of ATP, NADPH, and other intermediate energy metabolites in d-ribose treatment. Therefore, the strong non-enzymatic glycation ability of d-ribose may play an important role in erythrocyte damage.
Collapse
Affiliation(s)
- Zehong Zhang
- Institute of Blood Conservation, Baotou Medical College, 31# Jianshe Road, Donghe District, 014040 Baotou, Inner Mongolia, China
| | - Yu Tai
- Institute of Blood Conservation, Baotou Medical College, 31# Jianshe Road, Donghe District, 014040 Baotou, Inner Mongolia, China
| | - Zhi Liu
- Institute of Blood Conservation, Baotou Medical College, 31# Jianshe Road, Donghe District, 014040 Baotou, Inner Mongolia, China
| | - Yunxia Pu
- Physical and Chemical Laboratory, Inner Mongolia Center for Disease Control and Prevention, South Section of Yongping Road, Xincheng District, 010080 Hohhot, Inner Mongolia, China
| | - Liang An
- Clinical Laboratory, The Fourth Hospital of Baotou, 1(#) Aogen Road, Qingshan District, 014030, Baotou, Inner Mongolia, China
| | - Xiaojing Li
- Institute of Blood Conservation, Baotou Medical College, 31# Jianshe Road, Donghe District, 014040 Baotou, Inner Mongolia, China
| | - Lili Li
- Institute of Blood Conservation, Baotou Medical College, 31# Jianshe Road, Donghe District, 014040 Baotou, Inner Mongolia, China
| | - Yaqi Wang
- Institute of Blood Conservation, Baotou Medical College, 31# Jianshe Road, Donghe District, 014040 Baotou, Inner Mongolia, China
| | - Zhongbin Yang
- Institute of Blood Conservation, Baotou Medical College, 31# Jianshe Road, Donghe District, 014040 Baotou, Inner Mongolia, China
| | - Chao Duan
- Institute of Blood Conservation, Baotou Medical College, 31# Jianshe Road, Donghe District, 014040 Baotou, Inner Mongolia, China
| | - Kun Hou
- Physical and Chemical Laboratory, Inner Mongolia Center for Disease Control and Prevention, South Section of Yongping Road, Xincheng District, 010080 Hohhot, Inner Mongolia, China
| | - Qing Zhang
- Physical and Chemical Laboratory, Inner Mongolia Center for Disease Control and Prevention, South Section of Yongping Road, Xincheng District, 010080 Hohhot, Inner Mongolia, China
| | - Fuyu Ren
- Institute of Blood Conservation, Baotou Medical College, 31# Jianshe Road, Donghe District, 014040 Baotou, Inner Mongolia, China
| | - Qiang Ma
- Institute of Blood Conservation, Baotou Medical College, 31# Jianshe Road, Donghe District, 014040 Baotou, Inner Mongolia, China.
| | - Yan Su
- Institute of Blood Conservation, Baotou Medical College, 31# Jianshe Road, Donghe District, 014040 Baotou, Inner Mongolia, China.
| |
Collapse
|
2
|
Moschini R, Balestri F, Cappiello M, Signore G, Mura U, Del-Corso A. Ribose Intake as Food Integrator: Is It a Really Convenient Practice? Biomolecules 2022; 12:biom12121775. [PMID: 36551203 PMCID: PMC9776227 DOI: 10.3390/biom12121775] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2022] [Revised: 11/07/2022] [Accepted: 11/22/2022] [Indexed: 12/02/2022] Open
Abstract
Reports concerning the beneficial effects of D-ribose administration in cardiovascular and muscle stressful conditions has led to suggestions for the use of ribose as an energizing food supplement for healthy people. However, this practice still presents too many critical issues, suggesting that caution is needed. In fact, there are many possible negative effects of this sugar that we believe are underestimated, if not neglected, by the literature supporting the presentation of the product to the market. Here, the risks deriving from the use of free ribose as ATP source, forcing ribose-5-phosphate to enter into the pentose phosphate pathway, is emphasized. On the basis of the remarkable glycation capacity of ribose, the easily predictable cytotoxic effect of the molecule is also highlighted.
Collapse
Affiliation(s)
- Roberta Moschini
- Biochemistry Unit, Department of Biology, University of Pisa, Via San Zeno, 51, 56127 Pisa, Italy
- Interdepartmental Research Center Nutrafood “Nutraceuticals and Food for Health”, University of Pisa, 56124 Pisa, Italy
| | - Francesco Balestri
- Biochemistry Unit, Department of Biology, University of Pisa, Via San Zeno, 51, 56127 Pisa, Italy
- Interdepartmental Research Center Nutrafood “Nutraceuticals and Food for Health”, University of Pisa, 56124 Pisa, Italy
| | - Mario Cappiello
- Biochemistry Unit, Department of Biology, University of Pisa, Via San Zeno, 51, 56127 Pisa, Italy
- Interdepartmental Research Center Nutrafood “Nutraceuticals and Food for Health”, University of Pisa, 56124 Pisa, Italy
| | - Giovanni Signore
- Biochemistry Unit, Department of Biology, University of Pisa, Via San Zeno, 51, 56127 Pisa, Italy
- Interdepartmental Research Center Nutrafood “Nutraceuticals and Food for Health”, University of Pisa, 56124 Pisa, Italy
| | - Umberto Mura
- Biochemistry Unit, Department of Biology, University of Pisa, Via San Zeno, 51, 56127 Pisa, Italy
- Correspondence:
| | - Antonella Del-Corso
- Biochemistry Unit, Department of Biology, University of Pisa, Via San Zeno, 51, 56127 Pisa, Italy
- Interdepartmental Research Center Nutrafood “Nutraceuticals and Food for Health”, University of Pisa, 56124 Pisa, Italy
| |
Collapse
|
3
|
Li S, Wang J, Xiao Y, Zhang L, Fang J, Yang N, Zhang Z, Nasser MI, Qin H. D-ribose: Potential clinical applications in congestive heart failure and diabetes, and its complications (Review). Exp Ther Med 2021; 21:496. [PMID: 33791005 PMCID: PMC8005739 DOI: 10.3892/etm.2021.9927] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2020] [Accepted: 12/22/2020] [Indexed: 12/12/2022] Open
Abstract
The quality of life of patients with certain diseases may be improved through the development of technologies and advancements in pharmacology, with the aim of prolonging their life. However, congestive heart failure (CHF), as well their complications, continue to be the leading cause of disease-associated death. The mechanisms underlying the development and progression of diabetes and CHF have been uncovered in a stepwise manner and the understanding of these mechanisms has improved the management of these diseases, resulting in reduced mortality and morbidity rates; however, CHF remains the leading cause of death worldwide, particularly in developed countries. In the past decades, research has indicated that several supplements and naturally occurring compounds may be used to treat muscle weakness, for cardiac failure management, rehabilitation following myocardial ischemia-reperfusion and various complications of diabetes. D-ribose is an essential component of the respiratory, skeletal and nervous systems and is a popular compound, as its supplementation may have beneficial effects. In the present review, the physiological roles, toxic reactions and the potential use of D-ribose in the management of clinical diseases are summarized.
Collapse
Affiliation(s)
- Shuai Li
- Institute of Cytology and Genetics, Hengyang Medical College, University of South China, Hengyang, Hunan 421000, P.R. China
| | - Juanjing Wang
- School of Pharmaceutical Science, University of South China, Hengyang, Hunan 421000, P.R. China
| | - Yutian Xiao
- Institute of Cytology and Genetics, Hengyang Medical College, University of South China, Hengyang, Hunan 421000, P.R. China
| | - Li Zhang
- Institute of Cytology and Genetics, Hengyang Medical College, University of South China, Hengyang, Hunan 421000, P.R. China
| | - Jinren Fang
- Institute of Cytology and Genetics, Hengyang Medical College, University of South China, Hengyang, Hunan 421000, P.R. China
| | - Nanyang Yang
- Institute of Cytology and Genetics, Hengyang Medical College, University of South China, Hengyang, Hunan 421000, P.R. China.,The Hengyang Key Laboratory of Cellular Stress Biology, Institute of Cytology and Genetics, Hengyang Medical College, University of South China, Hengyang, Hunan 421000, P.R. China
| | - Zhixia Zhang
- Institute of Cytology and Genetics, Hengyang Medical College, University of South China, Hengyang, Hunan 421000, P.R. China
| | - Moussa Ide Nasser
- Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong 510100, P.R. China
| | - Hui Qin
- Institute of Cytology and Genetics, Hengyang Medical College, University of South China, Hengyang, Hunan 421000, P.R. China.,The Hengyang Key Laboratory of Cellular Stress Biology, Institute of Cytology and Genetics, Hengyang Medical College, University of South China, Hengyang, Hunan 421000, P.R. China
| |
Collapse
|
4
|
Cao W, Qiu J, Cai T, Yi L, Benardot D, Zou M. Effect of D-ribose supplementation on delayed onset muscle soreness induced by plyometric exercise in college students. J Int Soc Sports Nutr 2020; 17:42. [PMID: 32778175 PMCID: PMC7418385 DOI: 10.1186/s12970-020-00371-8] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2019] [Accepted: 08/02/2020] [Indexed: 11/22/2022] Open
Abstract
Objective Previous investigations suggest that appropriate nutritional interventions may reduce delayed onset muscle soreness (DOMS). This study examined the effect of D-ribose supplementation on DOMS induced by plyometric exercise. Methods For the purpose of inducing DOMS, 21 untrained male college students performed a lower-limb plyometric exercise session that involved 7 sets of 20 consecutive frog hops with 90-s of rest between each set. Muscle soreness was measured with a visual analogue scale 1-h before, 24-h after, and 48-h after exercise. Subjects were then randomly placed into the D-ribose group (DRIB, n = 11) and the placebo group (PLAC, n = 10) to assure equivalent BMI and muscle soreness. After a 14-d washout/recovery period, subjects performed the same exercise session, with DRIB ingesting a 200 ml solution containing 15 g D-ribose 1-h before, 1-h, 12-h, 24-h, and 36-h after exercise, and PLAC ingesting a calorically equivalent placebo of the same volume and taste containing sorbitol and β-cyclodextrin. Muscle soreness and isokinetic muscle strength were measured, and venous blood was assessed for markers of muscle damage and oxidative stress 1-h before, 24-h and 48-h after exercise. Results In DRIB, muscle soreness after 24-h and 48-h in the second exercise session were significantly lower (p < 0.01) than was experienced in the first exercise session. In the second exercise, blood-related markers of muscle soreness, including creatine kinase, lactate dehydrogenase (LDH), myoglobin and malondialdehyde (MDA) in DRIB after 24-h were lower in DRIB after 24-h than in PLAC (MDA, p < 0.05; rest outcomes, p < 0.01). In addition, LDH and MDA in DRIB were significantly lower (p < 0.01) after 24-h in DRIB than in PLAC. No difference was found in isokinetic muscle strength and oxidative stress markers, including superoxide dismutase and total antioxidant capacity, between DRIB and PLAC after 24-h and 48-h. Conclusion D-ribose supplementation reduces muscle soreness, improves recovery of muscle damage, and inhibits the formation of lipid peroxides. Young adult males performing plyometric exercise are likely to realize a DOMS reduction through consumption of D-ribose in 15 g/doses both before (1-h) and after (1-h, 12-h, 24-h, 36-h) exercise. These results suggest that appropriately timed consumption of D-ribose may induce a similar alleviation of exercise-induced DOMS in the general public.
Collapse
Affiliation(s)
- Wei Cao
- Department of Exercise Biochemistry, Exercise Science School, Beijing Sport University, No. 48 Xinxi Road, Haidian District, Beijing, China
| | - Junqiang Qiu
- Department of Exercise Biochemistry, Exercise Science School, Beijing Sport University, No. 48 Xinxi Road, Haidian District, Beijing, China.
| | - Tianwei Cai
- Department of Exercise Biochemistry, Exercise Science School, Beijing Sport University, No. 48 Xinxi Road, Haidian District, Beijing, China
| | - Longyan Yi
- Department of Exercise Biochemistry, Exercise Science School, Beijing Sport University, No. 48 Xinxi Road, Haidian District, Beijing, China
| | - Dan Benardot
- Department of Nutrition, Georgia State University, Atlanta, GA, USA.,Center for the Study of Human Health, Emory University, Atlanta, GA, USA
| | - Menghui Zou
- China Athletics College, Beijing Sport University, Beijing, BJ, China
| |
Collapse
|
5
|
van Tol W, van Scherpenzeel M, Alsady M, Riemersma M, Hermans E, Kragt E, Tasca G, Kamsteeg EJ, Pennings M, van Beusekom E, Vermeulen JR, van Bokhoven H, Voermans NC, Willemsen MA, Ashikov A, Lefeber DJ. Cytidine Diphosphate-Ribitol Analysis for Diagnostics and Treatment Monitoring of Cytidine Diphosphate-l-Ribitol Pyrophosphorylase A Muscular Dystrophy. Clin Chem 2019; 65:1295-1306. [PMID: 31375477 DOI: 10.1373/clinchem.2019.305391] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2019] [Accepted: 06/27/2019] [Indexed: 01/03/2023]
Abstract
BACKGROUND Many muscular dystrophies currently remain untreatable. Recently, dietary ribitol has been suggested as a treatment for cytidine diphosphate (CDP)-l-ribitol pyrophosphorylase A (CRPPA, ISPD), fukutin (FKTN), and fukutin-related protein (FKRP) myopathy, by raising CDP-ribitol concentrations. Thus, to facilitate fast diagnosis, treatment development, and treatment monitoring, sensitive detection of CDP-ribitol is required. METHODS An LC-MS method was optimized for CDP-ribitol in human and mice cells and tissues. RESULTS CDP-ribitol, the product of CRPPA, was detected in all major human and mouse tissues. Moreover, CDP-ribitol concentrations were reduced in fibroblasts and skeletal muscle biopsies from patients with CRPPA myopathy, showing that CDP-ribitol could serve as a diagnostic marker to identify patients with CRPPA with severe Walker-Warburg syndrome and mild limb-girdle muscular dystrophy (LGMD) phenotypes. A screen for potentially therapeutic monosaccharides revealed that ribose, in addition to ribitol, restored CDP-ribitol concentrations and the associated O-glycosylation defect of α-dystroglycan. As the effect occurred in a mutation-dependent manner, we established a CDP-ribitol blood test to facilitate diagnosis and predict individualized treatment response. Ex vivo incubation of blood cells with ribose or ribitol restored CDP-ribitol concentrations in a patient with CRPPA LGMD. CONCLUSIONS Sensitive detection of CDP-ribitol with LC-MS allows fast diagnosis of patients with severe and mild CRPPA myopathy. Ribose offers a readily testable dietary therapy for CRPPA myopathy, with possible applicability for patients with FKRP and FKTN myopathy. Evaluation of CDP-ribitol in blood is a promising tool for the evaluation and monitoring of dietary therapies for CRPPA myopathy in a patient-specific manner.
Collapse
Affiliation(s)
- Walinka van Tol
- Department of Neurology, Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Center, Nijmegen, the Netherlands.,Translational Metabolic Laboratory, Department of Laboratory Medicine, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands
| | - Monique van Scherpenzeel
- Translational Metabolic Laboratory, Department of Laboratory Medicine, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands
| | - Mohammad Alsady
- Department of Neurology, Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Center, Nijmegen, the Netherlands
| | - Moniek Riemersma
- Department of Neurology, Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Center, Nijmegen, the Netherlands
| | - Esther Hermans
- Department of Neurology, Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Center, Nijmegen, the Netherlands
| | - Else Kragt
- Translational Metabolic Laboratory, Department of Laboratory Medicine, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands
| | - Giorgio Tasca
- Unità Operativa Complessa di Neurologia, Dipartimento di Scienze dell'Invecchiamento, Neurologiche, Ortopediche e della Testa-Collo, Fondazione Policlinico A. Gemelli IRCCS, Roma, Italy
| | - Erik-Jan Kamsteeg
- Department of Human Genetics, Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Center, Nijmegen, the Netherlands
| | - Maartje Pennings
- Department of Human Genetics, Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Center, Nijmegen, the Netherlands
| | - Ellen van Beusekom
- Department of Human Genetics, Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Center, Nijmegen, the Netherlands
| | | | - Hans van Bokhoven
- Department of Human Genetics, Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Center, Nijmegen, the Netherlands
| | - Nicol C Voermans
- Department of Neurology, Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Center, Nijmegen, the Netherlands
| | - Michèl A Willemsen
- Department of Pediatric Neurology, Amalia Children's Hospital, Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Center, Nijmegen, the Netherlands
| | - Angel Ashikov
- Department of Neurology, Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Center, Nijmegen, the Netherlands
| | - Dirk J Lefeber
- Department of Neurology, Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Center, Nijmegen, the Netherlands; .,Translational Metabolic Laboratory, Department of Laboratory Medicine, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands
| |
Collapse
|